Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy
- DOI
- 10.1007/s11095-026-04198-x
- Published
- 2026-09-15
- Container
- Pharmaceutical Research
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s11095-026-04198-x,
title = {Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy},
author = {Aaditi Karnik and Girish Siddanagouda Hosmani and Sonam Dolma and Aditi Gangopadhyay and Amit Lalwani and Ramesh Babu Boga and D. Sriram and Punna Rao Ravi and Abhijeet R. Joshi},
year = {2026},
journal = {Pharmaceutical Research},
doi = {10.1007/s11095-026-04198-x},
url = {https://doi.org/10.1007/s11095-026-04198-x}
}RIS
TY - JOUR TI - Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy AU - Aaditi Karnik AU - Girish Siddanagouda Hosmani AU - Sonam Dolma AU - Aditi Gangopadhyay AU - Amit Lalwani AU - Ramesh Babu Boga AU - D. Sriram AU - Punna Rao Ravi AU - Abhijeet R. Joshi PY - 2026 JO - Pharmaceutical Research DO - 10.1007/s11095-026-04198-x UR - https://doi.org/10.1007/s11095-026-04198-x ER -
APA
Karnik, A., Hosmani, G. S., Dolma, S., Gangopadhyay, A., Lalwani, A., Boga, R. B., Sriram, D., Ravi, P. R., & Joshi, A. R. (2026). Preclinical Pharmacokinetic and Pharmacological Profiling of B339, a Novel SARM1 Inhibitor for the Treatment of Vincristine-induced Peripheral Neuropathy. Pharmaceutical Research. https://doi.org/10.1007/s11095-026-04198-x
Source records
- crossref · retrieved 2026-11-08T12:22:15.133Z